Astellas Sees Growth Potential for “Rx+” as Future Bread-and-Butter Biz: EVP

Astellas Pharma is revving up its beyond-the-pill drive by rolling out an array of what it calls the “Rx+” programs. The Japanese pharma giant expects that its bioelectronics and digital health initiatives as well as drug-device combination efforts might eventually...read more